Mark Kruzel, MD, MBA

serves as Medical Director of Oncology for Quest Diagnostics. Dr. Kruzel’s role bridges the gap from assay development to clinical utility, and he works to provide guidance on the appropriate utilization of testing. Dr. Kruzel has extensive research and industry experience ranging from managing an FDA trial site to commercializing a pharmaceutical compound for a start-up company. He has published numerous peer-reviewed journal articles as well as presented abstracts at both local and national conferences. Through his role at Quest, Dr. Kruzel has developed key opinion leader strategies, which help Quest advance the field of precision medicine.